© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
November 07, 2018
Treatment regimens consisting of daclatasvir plus sofosbuvir plus ribavirin and velpatasvir/sofosbuvir plus ribavirin show similar cure rates in patients with hepatitis C virus genotype 2 and 3.
October 11, 2018
The national Veterans Health Administration Corporate Data Warehouse could be key in revealing accurate data on the use of direct-acting antivirals in the treatment of chronic hepatitis C virus.
September 19, 2018
Study establishes real-world efficacy, tolerability, and safety profile of sofosbuvir-based regimens in patients with chronic hepatitis C who have compensated liver cirrhosis.
June 22, 2018
Testing for respiratory syncytial virus (RSV) infection during the influenza season is uncommon among pregnant mothers.
March 29, 2018
Tenofovir alafenamide plus emtricitabine can be safely used as an alternative to abacavir plus lamivudine in patients with HIV.
February 14, 2018
Exposure to high levels of estrogen and progesterone may help curb proinflammatory cytokine and chemokine expression associated with HIV-1.